Document is current
Any future updates will be listed below
-
Authors
Savolainen, Kalle http://orcid.org/0000-0002-1244-7200
Scaravilli, Mauro
Ilvesmäki, Antti
Staff, Synnöve
Tolonen, Teemu
Mäenpää, Johanna U.
Visakorpi, Tapio
Auranen, Annika
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02758652 at ClinicalTrials.govDocuments that mention this clinical trial
Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
https://doi.org/10.1186/s13104-020-05155-6
-
Funding
Funding for this research was provided by:
Suomen Kulttuurirahasto
Paulon Säätiö
Suomen Lääketieteen Säätiö
Relanderin Säätiö
Valtion tutkimusrahoitus
- License Information
-
More Information
Article History
Received: 16 May 2020
Accepted: 25 June 2020
First Online: 1 July 2020
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee of Tampere University Hospital (Identification Code R15134, 1.9.2015) and adhered to the principles in the Declaration of Helsinki. A written informed consent was obtained from each patient before sample collection for experimentation.
: Not applicable.
: The authors declare that they have no competing interests.
